Lumosity.com launches Italian version of cognitive training service

NewsGuard 100/100 Score

Lumosity.com, the leading online provider of games that improve brain performance, announced today the launch of an Italian version of their cognitive training service -- i.lumosity.com/it. The translation of the site into Italian was sponsored by Abbott Laboratories. Abbott also sponsored hundreds of memberships to make the Lumosity.com cognitive training program available to doctors and patients throughout Italy in an effort to raise awareness about the cognitive deficits associated with HIV/AIDS.

"We are very excited to bring this great cognitive training technology to the people of Italy," said Charles Guillemet, in charge of Lumosity.com's international development efforts. "Working with Abbott Laboratories has given us the tremendous opportunity to provide Lumosity.com in our fourth language and to distribute the training to a lot more people who really need it." The training programs are also available in English, Spanish, and French.

According to some estimates, close to 50% of patients with HIV suffer from associated neurocognitive disorders. Hundreds of doctors and patients throughout Italy will be provided with free 3-month memberships to i.lumosity.com/it thanks to the sponsorship of Abbott Laboratories and the support of the patient advocacy group Nadir ONLUS. In addition, 7-day free trial memberships will be available to all Italian speakers across the world. "We're hoping that this campaign increases awareness about the cognitive problems associated with HIV/AIDS," said Joe Hardy, PhD, Senior Director of Research and Development at Lumos Labs. "These efforts will also increase research interest in brain training for treating cognitive deficits associated with medical conditions that affect the brain, like HIV/AIDS."

Comments

  1. Angela Whellens Angela Whellens Italy says:

    Still waing to enrol

  2. Angela Whellens Angela Whellens Italy says:

    Would like to be part of The Lumosity training programme please.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common HIV drugs linked to reduced Alzheimer's disease risk